Glis3 is a member of the Glis subfamily of Krüppel-like zinc finger transcription factors. Recently, Glis3 has been linked to both type I and type II diabetes and has been shown to positively regulate insulin gene expression. In this study, we identify a region within the Nterminus of Glis3 sharing high levels of homology with the Ci/Gli family of proteins. We demonstrate that Glis3 interacts with Suppressor of Fused (SUFU) involving a VYGHF motif located within this conserved region. We further show that SUFU is able to inhibit the activation of the insulin promoter by Glis3, but not the activation by a Glis3 mutant deficient in its ability to bind SUFU, suggesting that the inhibitory effect is dependent on the interaction between the two proteins. Exogenous SUFU did not affect the nuclear localization of Glis3; however, Glis3 promoted the nuclear accumulation of SUFU. Additionally, we demonstrate that SUFU stabilizes Glis3 in part by antagonizing Glis3 association with a Cullin 3-based E3 ubiquitin ligase that promotes the ubiquitination and degradation of Glis3. This is the first reported instance of Glis3 interacting with SUFU and suggests a novel role for SUFU in the modulation of Glis3 signaling. Given the critical role of Glis3 in pancreatic !-cell generation and maintenance, the elevated Glis3 expression in several cancers and the established role of SUFU as a tumor suppressor, these data provide further insight into Glis3 regulation and its function in development and disease.
Gli-similar 1-3 (Glis1-3) constitute a distinct subfamily of Krüppel-like zinc finger transcription factors that are related to members of the Gli family and the Drosophila homolog Cubitus interruptus (Ci), the downstream effectors of Hedgehog signaling, and to proteins in the Zic family (1) (2) (3) . Homology between Glis, Zic, and Ci/Gli proteins is limited to the five Cys 2 -His 2 zinc finger motifs shared by all three subfamilies with little or no similarity outside the region (4) . The zinc finger domain of Glis3 is required for the recognition of specific DNA binding sites within the regulatory regions of target genes (4) (5) (6) (7) (8) . In vitro studies have shown that Glis3 optimally binds the consensus sequence, 5'-(G/C)TGGGGGGT(A/C), designated as the GlisBS (9) . In addition to its zinc finger domain (ZFD), the Glis3 C-terminus has proven indispensable for transactivation, while little is currently known about the role of its N-terminus (4, 9) .
Glis3 has been implicated in the regulation of several physiological processes, including osteoblast differentiation, pancreatic development, and the maintenance of normal renal functions (1, 5, 6, 10, 11) . Genetic aberrations in the GLIS3 gene have been linked to the development of neonatal diabetes and congenital hypothyroidism (NDH), polycystic kidney disease, liver fibrosis, as well as type 1 and type 2 diabetes (11) (12) (13) (14) (15) (16) . Mice with disrupted Glis3 function develop neonatal diabetes, hypothyroidism, and polycystic kidney disease (6, 7, 17) . Recently, Glis3 has been shown to positively regulate transcription of the human proinsulin (INS) and rodent insulin 2 (Ins2) genes in pancreatic !-cells (7, 8) . Transcriptional regulation and !-cell specific expression of the insulin gene occurs via an approximately 600 bp upstream regulatory region (18, 19) . The most notable elements within the insulin promoter are the A, E, and C-boxes, which bind Pdx1, !2/NeuroD1, and MafA, respectively. Glis3 induces insulin gene expression through two GlisBS within the proximal promoter region (7, 8) . Thus far, little is known about the precise mechanisms that control Glis3 activation and Glis3-induced transcription.
Previous studies have shown that the DNAbinding domain and transcriptional activation domain are localized in the center and within the C-terminus of Glis3, respectively (1, 4, 9) ; however, little is known about the function of its 500 amino acid N-terminus. The objective of this study is to examine the potential role of the Nterminus in modulating Glis3 activity. Analysis of a series of N-terminal deletions within Glis3 indicated the presence of several regulatory domains that influence the transcriptional activity and the stability of Glis3. In addition, we identified a region within the N-terminus of Glis3 that shares high homology with a corresponding region of Ci and its mammalian homologs, Gli1-3. We show that the tumor suppressor Suppressor of Fused (SUFU) interacts with Glis3 through a VYGHF motif within this N-terminal conserved region and functions as a modulator of Glis3 signaling. SUFU was able to inhibit the Glis3-mediated activation of the insulin promoter and protected Glis3 protein against proteasomal degradation. We provide evidence for a role of the E3 ubiquitin ligase scaffolding component, Cullin 3 (Cul3), in the regulation of Glis3 protein stability. Cul3 associates with Glis3 at a degron located within the Glis3 N-terminal conserved region and subsequently promotes Glis3 polyubiquitination and degradation via the 26S proteasomal pathway. Our data suggests that the inhibition of the association of Cul3 with Glis3 by SUFU is in part responsible for the decreased Glis3 ubiquitination and increased protein stabilization. This is the first report identifying SUFU as an interacting partner of Glis3. Our study suggests a novel role for SUFU in the modulation of different aspects of the Glis3 signaling pathway, including the transcriptional regulation of target genes and protein stability.
MATERIALS & METHODS

Cells and Growth
Conditions -Rat insulinoma INS-1 (832/13) cells were a generous gift from Dr. H. Hohmeier (Duke University) and were maintained in RPMI 1640 supplemented with 10% fetal calf serum, 10 mM HEPES, 2 mM glutamine, 1 mM sodium pyruvate, 100 U/ml penicillin, 100 µg/ml streptomycin, and 50 µM !-mercaptoethanol. HEK293 and IMCD3 cells were purchased from ATCC and cultured in DMEM containing 10% FBS and in DMEM and F12 medium (1:1) supplemented with 10% FBS, respectively.
Generation of Reporter and Expression Constructs -
The generation of p3xFlag-CMV-Glis1, p3xFlag-CMV-Glis2, p3xFlag-CMV-Glis3, p3xFlagCMV-Glis3!N302, p3xFlag-CMV-Glis2"N58, p3xFlag-CMV-Glis2"N160, and p3xFlag-CMVGlis2"C169 was described previously (6, 9, 20, 21) . The plasmids p3xFlag-CMV-Glis3!N34, 65, 155, 288, 295, 319, 333, 355, and 388 and p3xFlag-CMV-Glis3!C389 were generated by PCR amplification of the respective fragments and inserting them into the EcoRI and BamHI restriction sites of the p3xFlag-CMV10 expression vector (Sigma). pCMV-Myc-SUFU was kindly provided by Rune Toftgard (Karolinska Institutet, Huddinge, Sweden)(22).
The mIP-(696)-Luc luciferase reporter construct was described previously (6) . pM-Glis3 was generated by inserting the full-length coding region of Glis3 into the pM expression vector (Clontech) following PCR amplification. pVP16-SUFU was created by inserting PCR amplified full-length SUFU into the VP16 vector (Clontech). pCMVCul3-Myc was a generous gift from Dr. Jun Yan (UNC, Chapel Hill). pEGFP-Glis1-3 and pSUFUDsRed were produced by cloning the full-length coding region of Glis1-3 or SUFU into pEGFP-C2 or pDsRed2-N1, respectively (Clontech). Site directed mutagenesis of the p3xFlag-CMV-Glis3, p3xFlag-CMV-Glis3"N302, and pM-Glis3 was carried out using the Quickchange Site Directed Mutagenesis Kit (Stratagene) following the manufacturer's protocol. The primer sets utilized follow with mutated bases underlined: Glis3 Y349A: 5'-CAGTCAGAGGTCGCTGGGCAT- TTCCTGG and 5'-CCAGGAAATGCCCAGCG-ACCTCTGACTG; Glis3 G350A: 5'-GTCAG-AGGTCTATGCGCATTTCCTGGGTG and 5'-CACCCAGGAAATGCGCATAGACCTCTGAC;  Glis3  H351A:  5'-GTCAGAGGTCTATG-GGGCTTTCCTGGGTG  and  5'-CACCCAGGAAAGCCCCATAGACCTCTGAC;  Glis3 GH!AA: 5'-GTCAGAGGTCTATGCG-GCTTTCCTGGGT and 5'-CACCCAGGAAA-GCCGCATAGACCTCTGAC; Glis3 YGH!AAA: 5'-CAGTCAGAGGTCGCTGCG-GCTTTCCTGG and 5'-CCAGGAAAGC-CGCAGCGACCTCTGACTG. All constructs were verified by restriction enzyme analysis and DNA sequencing. Reporter Assays -Cells were plated in 12-well dishes at 1 x 10 5 cells/well and incubated for 24 h at 37°C. Cells were subsequently transfected with 1mg of the indicated reporter, 0.3 µg pCMV-!-galactosidase, and 0.5 µg of the indicated expression vector in Opti-MEM (Gibco) using LipofectAMINE 2000 (Invitrogen) per the manufacturer's instructions. Each transfection was carried out in triplicate. Cells were harvested after 24 h by scraping directly into 125 µl Reporter Lysis Buffer and luciferase activity was measured using a luciferase assay kit (Promega).
!-galactosidase levels were measured using a luminometric !-galactosidase detection kit (Clontech) following the manufacturer's protocol. Each data point was assayed in triplicate and each experiment was performed at least twice. Relative luciferase activity was calculated. All values underwent ANOVA and Tukey-Kramer comparison tests using InStat software (GraphPad Software Inc) and data is presented as mean ± SEM.
Mammalian 2-hybrid assays were performed with HEK293 cells, plated in 12-well dishes at 1 x 10 5 cells/well and incubated for 24 h at 37°C. Cells were subsequently transfected with pM or VP16 empty vector (Clontech), pVP16-SUFU, pM-Glis3, or the specified pM-Glis3 mutant, pFR-Luc, and pCMV-Beta-Gal diluted in OptiMEM (Gibco) and incubated with LipofectAMINE 2000 reagent according to the manufacturer's protocol (Invitrogen). Cells were harvested and luciferase assays were conducted and analyzed as reported above. Co-immunoprecipitation Assays -HEK293 cells were transiently transfected with the specified plasmids using LipofectAMINE 2000 reagent (Invitrogen) following the manufacturer's protocol. 48 h after transfection, cells were harvested by scraping in RIPA Buffer (25 mM Tris, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 20 mM sodium molybdate, 0.5% NP-40) containing protease and protease inhibitor cocktails I and II (Sigma). Cell lysates were centrifuged at 16,000 x g for 10 min at 4°C and half the supernatant was stored at -70°C for the input fractions.
The remaining half of the supernatant was incubated at 4°C for 60 min with either 2 µg mouse-anti-Myc (Invitrogen) or 1 µg mouse-anti-M2 Flag (Sigma Aldrich) antibody. Protein complexes were immobilized by incubating with protein-G Sepharose beads for 2 h at 4°C. Beads were washed three times with 600 µl ice-cold RIPA buffer and proteins were released from the beads by boiling for 5 min in the presence of 1x Laemmli buffer.
Input and immunoprecipitated proteins were examined by Western blot analysis using mouse anti-Flag or mouse anti-Myc antibodies. Quantitative Reverse Transcriptase Real Time PCR Analysis -INS1 (832/13) cells were transiently transfected with p3xFlag-CMV10 empty vector, p3xFlag-CMV-Glis3"N302, and/or pCMV-SUFU-Myc using LipofectAMINE 2000 reagent following the manufacturer's protocol (Invitrogen). RNA was isolated from the cells after 48 h using an RNeasy mini kit (Qiagen) according to the manufacturer's specifications. Equal amounts of RNA were used to generate cDNA using a high-capacity cDNA kit (Applied Biosystems) and cDNA was analyzed by quantitative real time PCR. All qRT-PCR was performed in triplicate using a StepOne Plus real time PCR system (Applied Biosystems Proteins were quantified by scanning autoradiograms into Adobe Photoshop (Adobe Systems Inc.) and measuring the mean intensity and pixel count of pertinent bands selected with the Lasso tool. The mean intensity and pixel count of experimental bands were multiplied and divided by the mean intensity multiplied by the pixel count of GAPDH bands, used for normalization. All samples were run in duplicate and all experiments performed at least twice. Data shown is the average of duplicate samples +/-SEM.
RESULTS
The amino terminal region of Glis3 influences
Glis3-mediated transcriptional regulation. Previous studies focused predominantly on two domains within Glis3; the centrally located ZFD, which mediates the recognition of GlisBS, and a transactivation domain (TAD) within the Cterminus of Glis3 that is required for its transactivation function (1, 4, 9) . We previously reported that Glis3 robustly activates transcription of murine Ins2 via its proximal promoter, which contains two functional Glis responsive elements (7, 8) . In order to assess the potential role of the Glis3 N-terminus in modulating Glis3 transcriptional activity, we examined the effect of various N-terminal deletions on the activation of the Ins2 promoter. Luciferase reporter assays were carried out by transfecting rat !-like INS1 (832/13) cells with p-mIP(-696)-Luc, a reporter under control of the Ins2 upstream regulatory region spanning nucleotides -696 to +8, relative to the transcriptional start site. p-mIP(-696)-Luc was co-transfected with either an expression vector encoding the full-length Glis3 (p3xFlag-CMVGlis3) or one of a series of Glis3 mutants serially truncated at the N-terminus. Progressive deletions of the Glis3 N-terminus resulted in enhanced reporter gene activity that reached a maximum with Glis3!N302 and diminished with subsequent deletions (Fig. 1A) . In order to determine whether the observed pattern of regulation was !-cell specific, the experiment was repeated in HEK293 cells, which were previously used to demonstrate the ability of Glis3 to activate a (GlisBS) 6 driven reporter (9) . The pattern of transcriptional activation by various Glis3 mutants observed in HEK293 cells was qualitatively very similar to that observed in INS1 cells (Fig. 1B) . Western blot analysis revealed that the corresponding levels of Flag-tagged Glis3 proteins expressed in HEK293 cells varied significantly between the mutants (Fig. 1C) , but did not correlate with their level of transactivation. Deletions within the first 155 amino acids had a relatively slight effect on Glis3-mediated activation of the Ins2 promoter. The level of activation was significantly increased upon further deletions at the N-terminus and reached a maximum with the mutant Glis3"302 lacking the first 302 amino acids, while subsequent N-terminal deletions caused a reduction in transactivation. These data indicated that several regions within the Glis3 N-terminus might be involved in modulating Glis3 transactivation activity. Analysis of the level of the various mutant Glis3 proteins suggested that deletion of the first 319 amino acids might result in the stabilization of the Glis3 protein.
The region of Glis3 between amino acids 296 and 354 is highly conserved with a region in the N-terminus of Ci/Gli proteins.
To ascertain whether the Glis3 N-terminus contained a region exhibiting sequence homology with a recognized domain found in other proteins, the region was subjected to a BLASTp search of the NCBI database. This comparison revealed that the region between amino acids 296 and 354 not only showed high levels of homology among Glis3 proteins from various species ranging from fishes to humans, but also to a highly conserved region within Gli1, 2, and 3, and the Drosophila homolog Ci. The N-terminus of Glis3 and Gli proteins exhibited little sequence homology beyond this region. A multiple sequence alignment of the conserved region revealed particularly high by guest on January 9, 2018 http://www.jbc.org/ Downloaded from homology ("70% similarity) between residues 296-338 of murine Glis3 and the corresponding regions within Glis3 homologs and Gli proteins ( Fig. 2A) . This region contains a conserved basic sequence between aa 295-302. In addition, a highly conserved motif, (S/V)YGH(F/L), was found between aa 348-352. The 58 aa conserved region of Glis3 further contains a number of potential phosphorylation sites. In fact, the region is composed of 28% serine, threonine, and tyrosine. Interestingly, sequence analysis did not identify any significant regions of homology in the N-terminus of Glis3 with that of Glis1 or Glis2, indicating that the presence of this conserved region is unique to the Glis3 member of the Glis protein subfamily. The phylogenetic relationship between the N-terminal homologous regions of Glis3, Gli proteins, and Ci is shown in Fig. 2B . Glis3 interacts with SUFU. A proteome scale yeast-two-hybrid screening presented evidence that Glis3 may associate with the tumor suppressor and negative regulator of Hedgehog signaling, SUFU; however, no further characterization of this potential interaction was carried out (23) . We, therefore, performed co-immunoprecipitation assays to determine whether or not Glis3 was indeed capable of interacting with SUFU. HEK293 cells were co-transfected with an Nterminal Myc-tagged human SUFU construct (pCMV-SUFU-Myc) and either p3xFlag-CMV10 empty vector, or p3xFlag-CMV-Glis3 or p3xFlag-CMV-GLIS3 containing full-length murine or human Glis3 respectively.
As SUFU had previously been shown to interact with GLI1 (22,24,25), Flag-GLI1 was used as a positive control. A representative experiment shown in Figure 3A demonstrated that both human and murine Glis3 co-immunoprecipitated with SUFU, suggesting that Glis3 and SUFU interact. In order to determine the region of Glis3 involved in the interaction with SUFU, HEK293 cells were transfected with pCMV-SUFU-Myc, p3xFlag-CMV-Glis3 or p3xFlag-CMV-Glis3!N388 or p3xFlag-CMV-Glis3!C389 encoding Flag-tagged Glis3 mutants in which, respectively, the first 388 amino acids or the zinc finger and C-terminus were deleted.
Both full-length Glis3 and Glis3!C389 co-precipitated with SUFU; however, Glis3!N388 was incapable of forming a complex with SUFU, indicating that the first 388 amino acids of Glis3 are required for the interaction with SUFU (Fig. 3B ). The ability of SUFU to interact with the deletion mutant Glis3!N333, but not Glis3!N355, further narrowed down the region of SUFU interaction to the amino acids between 334 and 355 (Fig. 3C) .
A previous report showed that protein-protein interactions by SUFU involve recognition of an SYGH motif (22). Interestingly, Glis3 contains a similar motif, VYGH, located between amino acids 348 and 351 within the conserved region described above ( Fig. 2A) .
To assess the importance of these residues in Glis3-SUFU binding, in vitro mutagenesis was utilized to mutate Tyr 349 , Gly 350 , and His 351 to alanine, alone or in combination. Co-IP experiments revealed that the Y349A mutation had little effect on the interaction; however, mutation of the glycine and histidine at positions 350 and 351, respectively, dramatically reduced association between the two proteins ( Fig. 3D) . To obtain further support for this interaction, mammalian 2-hybrid analyses were performed utilizing pFR-Luc, pVP16-SUFU, and pM-Glis3 expressing Glis3 or various Glis3 YGH mutants fused to the GAL4 DNA binding domain. The representative data shown in Figure  3E were consistent with the conclusion that Glis3 and SUFU interacted. Mutation of Gly 350 and His 351 was sufficient to virtually eliminate all interaction between the proteins. In contrast to the Co-IP results, the Y349A mutation significantly reduced the interaction between Glis3 and SUFU in the 2-hybrid analysis.
Glis3 and SUFU co-localized to the nucleus. Since SUFU was capable of interacting with Glis3, it was of interest to investigate whether this interaction affected the sub-cellular localization of either SUFU or Glis3. Confocal microscopy was utilized to examine the sub-cellular localization of N-terminal EGFP-tagged Glis3 and C-terminal tagged SUFU-DsRed fusion proteins. IMCD3 cells were used because of their relatively large size and distinct cytoplasmic and nuclear compartments. EGFP-Glis3 protein was localized mainly in the nuclear compartment of IMCD3 cells both in the presence or absence of SUFU (Fig. 4A) .
SUFU-DsRed was observed predominantly in the cytoplasm and to a lesser degree in the nucleus when expressed alone in agreement with previous reports (22,26); however, SUFU was largely (>80% of cells) localized to the nucleus in cells in which SUFU was co-expressed with Glis3 (Fig. 4A) . In contrast, SUFU-DsRed remained predominantly cytoplasmic (in >70% of transfected cells) when co-expressed with the EGFP-Glis3-YGH!AAA mutant that exhibit a reduced interaction with SUFU. Similar results were obtained in HEK293 and INS1 cells (data not shown).
SUFU inhibits Glis3-mediated Ins2 transactivation. Given the apparent association between Glis3 and SUFU, it was important to determine whether SUFU had an effect on Glis3-mediated Ins2 transcriptional regulation.
To examine the effect of SUFU on the induction of Ins2 mRNA expression, we transiently transfected INS1(832/13) cells with empty vector or p3xFlag-CMV-Glis3!N302 either with or without pCMV-SUFU-Myc. As shown in Figure 5A , expression of exogenous Glis3!N302 increased Ins2 mRNA levels nearly 4-fold, while SUFU overexpression reduced the basal level of Ins2 mRNA by approximately 40%. Co-expression of pCMV-SUFU-Myc with p3xFlag-CMV-Glis3!N302 likewise reduced Ins2 mRNA levels by approximately 40% compared to expression of Glis3!N302 alone. To further assess the role of SUFU as a transcriptional modulator of Ins2, INS1(832/13) cells were transiently transfected with p-mIP(-696)-Luc, p3xFlag-CMV-Glis3, and either pCMV-SUFU-Myc or empty vector. Luciferase reporter analyses indicated that coexpression with SUFU significantly reduced the activation of the mIP(-696) promoter by fulllength Glis3 and the Glis3 N-terminal truncation mutants up to Glis3!N319 (Fig. 5B, C) , consistent with the reduction in Ins2 mRNA levels (Fig. 5A) . In contrast, SUFU did not inhibit the activation of the Ins2 promoter by Glis3!N355, Glis3!N388, or Glis3-YGH!AAA, mutants that did not bind SUFU or exhibited a reduced interaction with SUFU, respectively (Fig. 5C ). These data indicate that the inhibition of Glis3-mediated transactivation by SUFU appears to rely on the interaction with Glis3 through the YGH motif and was not related to an effect on the general transcriptional machinery. Interestingly, SUFU affected the Glis3!N333-induced transactivation only to a small degree despite the ability of the two proteins to interact (Fig. 3C) , suggesting that the region between amino acids 319 and 333 of Glis3 may also play a role in the inhibition by SUFU.
Even though SUFU repressed the transactivation mediated by Glis3 and Glis3 mutants truncated up to amino acid 319, Western blot analysis revealed that it significantly increased the level of the respective Glis3 protein (Fig. 5D) . However, SUFU appeared to have little effect on the protein levels of Glis3 mutants truncated beyond aa 319 nor did it affect the level of the full-length YGHmutant as considerably as observed with the wild type Glis3. Collectively, these data suggested that both the sequence of amino acids between 303-333 within the homologous region of Glis3 and interaction with SUFU play an important role in modulating the transcriptional activity of Glis3 as well as in the regulation of Glis3 protein stability.
SUFU protects Glis3 against proteasomal degradation. To obtain further support for our conclusion that co-expression with SUFU causes an increase in Glis3 protein levels, p3xFlag-CMVGlis3 was transfected into HEK293 cells with increasing concentrations of pCMV-SUFU-Myc and 48 h later the level of Glis3 protein analyzed. As shown in Figure 6A , the increase in Glis3 protein levels corresponded to the graded increase in SUFU. SUFU had a reduced effect on the level of the Glis3-YGH!AAA mutant that interacted weakly with SUFU. To determine the effect of SUFU on Glis3 protein stability, HEK293 cells transfected with p3xFlag-CMV-Glis3 and either pCMV-SUFU-Myc or Myc empty vector were treated with cycloheximide and the level of Glis3 protein was determined over a period of 6 h. The results showed that Glis3 exhibited a calculated half-life of 4.5 h in cells transfected with Glis3 only (Fig. 6B) , while in cells co-transfected with SUFU its half-life increased to 15.4 h indicating that co-expression with SUFU enhanced the stability of Glis3 protein and protected Glis3 from proteolytic degradation. This was consistent with data showing that the increase in Glis3 levels by SUFU was not due to changes in the regulation of Glis3 mRNA, as determined by qRT-PCR ( Figure  6C ). Moreover, treatment with the proteasome inhibitor MG132 caused a 2.5 or 3-fold increase in Glis3 protein levels indicating that proteolytic degradation of Glis3 is mediated by the 26S proteasome (Fig. 6D) . In addition, coimmunoprecipitation analysis utilizing HEK293 cells co-transfected with p3xFlag-CMV-Glis3 and pCMV-HA-Ub, expressing HA-tagged ubiquitin, demonstrated that Glis3 was ubiquitinated and that by guest on January 9, 2018 http://www.jbc.org/ Downloaded from co-transfection with pCMV-SUFU-Myc dramatically reduced Glis3 ubiquitination (Fig.  6E) . Collectively, these findings support a role for SUFU in the regulation of Glis3 protein stability.
SUFU associates with Glis2. In order to determine whether the association with SUFU was specific to Glis3 amongst members of the Glis subfamily, co-immunoprecipitation analyses were carried out with HEK293 cells transiently transfected with pCMV-SUFU-Myc and p3xFlag-CMV expressing Glis1 or Glis2. Figure 7A shows that SUFU co-immunoprecipitated with Glis2, albeit to a lesser degree than was observed with Glis3, while SUFU did not co-immunoprecipitate with Glis1. These data suggested that SUFU can be part of a Glis2 protein complex, but under the experimental conditions tested, does not interact with Glis1. Because Glis2 does not contain an YGH-like motif, its interaction with SUFU must be mediated by another mechanism. To further narrow down the region of Glis2 involved in this interaction, the effect of an N-and C-terminal truncation on the interaction was examined. Coimmunoprecipitation analyses indicated that SUFU was able to interact with Glis2"N160, containing the ZFD and C-terminus, but not with the N-terminal region, Glis2"C169 (Fig. 7B) . Previously, we reported that Glis2 was able to activate the mIP(-696)-Luc reporter in HEK293 cells (21) . We, therefore, examined whether SUFU had any effect on the transactivation of the Ins2 promoter by Glis2. In contrast to Glis3, SUFU had little effect on Glis2-mediated transactivation of the Ins2 promoter (Fig. 7C) . Glis1 was also able to activate the Ins2 promoter, but this activation was slightly enhanced rather than inhibited by SUFU co-expression. Next, we examined whether SUFU affected Glis1 or Glis2 protein stability. As shown in Figure 7D , SUFU did not influence the level of Glis1 or Glis2 protein. These observations indicated that in contrast to Glis3, SUFU did not affect the transactivating activity or stability of Glis1 or Glis2.
Glis3 degradation is mediated by Cul3. The polyubiquitination and subsequent degradation of Glis3 by the proteasome system may involve several E3 ubiquitin ligases, including cullin-based E3 ubiquitin ligases (27) . In order to determine whether the E3 ubiquitin ligase scaffolding protein, Cullin 3 (Cul3) (28-30) was able to promote the ubiquitination of Glis3, Flag-tagged Glis3 was immunoprecipitated with HA-tagged ubiquitin in the presence or absence of coexpression with exogenous Cul3. Figure 8A shows that co-expression of Glis3 with Cul3 resulted in a significant increase in the amount of ubiquitinated Glis3 detected consistent with the hypothesis that Cul3 promotes Glis3 degradation. To determine whether Cul3 associates with Glis3, co-immunoprecipitation analysis was performed in HEK293 cells cotransfected with p3xFlag-CMVGlis3, p3xFlag-CMV-Glis3!N155, p3xFlag-CMVGlis3!N302, or p3xFlag-CMV-Glis3!N319, and pCMV-Cul3-Myc as indicated. As seen in Figure  8B , Cul3 co-immunoprecipitated with full-length Glis3 as well as with Glis3"N155 and Glis3"N302 lacking, respectively, the first 155 or 302 amino acids, but interacted only weakly with Glis3"N319 suggesting that the region between amino acids 302 and 319 was required for optimal Glis3-Cul3 interaction. Interestingly, this region was also associated with enhanced levels of Glis3 protein expression following N-terminal deletions ( Fig. 1C and 5D ).
To determine whether SUFU influenced the association between Cul3 and Glis3, we examined the effect of increased expression of SUFU on this interaction. As shown in Fig. 8C , increasing levels of SUFU significantly decreased the amount of Glis3 that co-immunoprecipitated with Cul3, while increasing the input level of Glis3. These results are consistent with the hypothesis that SUFU antagonized the interaction of Cul3 with Glis3. In contrast, SUFU had little effect on the interaction of Cul3 with the Glis3-YGH!AAA mutant, which binds SUFU only weakly, and had little effect on the input level of mutant Glis3 (Fig. 8C) . The ectopic expression of Cul3 did not cause a decrease in Glis3 protein input levels suggesting that it did not appear to substantially enhance the overall rate of Glis3 degradation despite increased Glis3 polyubiquitination. Possibly the endogenous level of other components of the Cul3-based E3 ubiquitin ligase complexes may be limiting resulting in less than optimal Cul3-dependent degradation. Our data are consistent with the hypothesis that Cul3-based E3 ubiquitin ligases play a part in promoting the polyubiquitination of Glis3, while SUFU reduces Glis3 association with Cul3, thereby stabilizing Glis3.
DISCUSSION
Beyond a DNA-binding domain in the center of Glis3 and an activation domain at its Cterminus, little is further known about the domain structure of the Glis3 protein, particularly the function of its 500 amino acid N-terminus. In this study, we demonstrate for the first time that the Nterminus of Glis3 plays a critical role in modulating the stability and transcriptional activity of Glis3 and that part of this regulation is mediated through interactions with SUFU and Cul3 within the N-terminus.
In silico examination of the Glis3 N-terminus revealed a region between amino acids 296 and 354 that is highly conserved among Glis3 homologs of different species, including that of human, mouse, and zebrafish ( Fig. 2A) . This region also exhibits high homology to a corresponding region in Gli1-3 and Ci, but was not found in Glis1 or Glis2. The high level of homology suggests that this region may play a critical role in regulating the function of these proteins. Although most of the function of this region has yet to be established, a role for an SYGHXS consensus motif at the C-terminal end of the homologous region of Gli proteins, identified as critical for interaction with SUFU, has emerged (22,31). In this study, we demonstrated that SUFU interacted with Glis3 through a similar motif, VYGHF 352 , within this conserved region. Mutation of Gly 350 and His 351 to Ala greatly diminished the interaction of Glis3 with SUFU suggesting that the VYGHF motif is important for this interaction. Our observation that SUFU can interact with the N-terminus of Glis3, but not its C-terminus, is consistent with this conclusion. Mutation of Tyr 349 to Ala had little effect on the interaction as determined by coimmunoprecipitation assays; however, this mutation did significantly reduce the interaction detected by mammalian 2-hybrid assay. Similarly, an analogous mutation in Tyr 121 of Gli1 was reported not to influence its interaction with SUFU as determined by Far Western analysis (22). Of the other Glis family members, only Glis2 was able to interact with SUFU. The association with SUFU was maintained following the deletion of the Nterminus of Glis2, but abolished with deletion of the region including the ZFD and the C-terminus. This region does not contain a SYGHXS-like, SUFU-interaction motif indicating that SUFU interacts with the Glis2 C-terminal region via a different domain or interacts indirectly with Glis2.
Our data further indicate that the N-terminus of Glis3, particularly the conserved region, and its interaction with SUFU play a role in regulating the stability of Glis3 protein. Co-expression with SUFU enhanced the level of Glis3 protein without affecting Glis3 mRNA levels. This increase in Glis3 protein was found to be at least partly related to an inhibition in the proteolytic degradation of Glis3. This, combined with the observation that SUFU inhibited Glis3 polyubiquitination, suggested that the increased stability of Glis3 is due to decreased proteasomal degradation. The increase in Glis3 protein stability was at least partly dependent on its YGH motif suggesting that SUFU interaction at this motif was important for its effect on Glis3 protein stability. However, we cannot rule out that SUFU may regulate Glis3 protein levels by other mechanisms, including translational control. Despite its interaction with Glis2, SUFU had no apparent effect on the stability of Glis2 protein.
Proteasomal degradation of Glis3 may be an important mechanism in regulating Glis3 function by tightly controlling the level of Glis3 protein.
The increase in Glis3 protein level observed after the addition of the proteasome inhibitor MG132 is consistent with proteolytic degradation of Glis3 by the proteasome system. The latter may involve a number of different E3 ubiquitin ligases. One large family of E3 ubiquitin ligases consists of multi-subunit protein complexes organized by the Cullin family of scaffolding proteins (27) . Our study provides evidence for a role of Cul3-based E3 ubiquitin ligases in the regulation of Glis3 protein stability and a possible connection between the action of Cul3, SUFU, and Glis3. Cul3 typically promotes ubiquitin-dependent proteolytic degradation by binding to the BTB-domain of adaptor proteins that target specific protein substrates (27) , therefore, it is likely that association between Cul3 and Glis3 is mediated by a similar mechanism. We demonstrated that Cul3 is part of a Glis3 protein complex and is able to promote the polyubiquitination of Glis3. Truncation of the Glis3 N-terminus up to amino acid 302 had little effect on its interaction with by guest on January 9, 2018 http://www.jbc.org/ Downloaded from Cul3, whereas deletion beyond amino acid 319 dramatically reduced the interaction (Fig. 8B) . We showed that deletion of the same region also results in a significant increase in Glis3 protein expression levels (Fig. 1C) . This correlation is consistent with the presence of a degron located within the region between amino acids 302 and 319. While Glis3"N319 appears stabilized relative to full-length Glis3, further stabilization is observed in the presence of SUFU while SUFU had no observable effects on the stabilization of Glis3 "N333-388. Coupled with the significantly weakened, but detectable, interaction of Glis3"N319 with Cul3, these data indicate that the putative degron may extend up as far as amino acid 333. Our data further indicated that SUFU inhibited the association between Glis3 and Cul3. This together with the observation that SUFU inhibits the level of Glis3 ubiquitination suggests that SUFU may stabilize Glis3 by inhibiting Cul3-Glis3 interaction and Cul3-mediated ubiquitination of Glis3. Previous studies reported that SUFU is able to stabilize Gli2 and Gli3 against proteasomal degradation by antagonizing their interaction with SPOP/Cul3 (30, 32) . However, we were unable to observe any effects of SPOP on Glis3 (ZeRuth, G., unpublished data), suggesting that another BTBdomain containing protein may mediate the interaction between Glis3 and Cul3.
In addition to an effect on protein stability, SUFU was shown to inhibit the transcriptional activity of Glis3. In a previous report we demonstrated that Glis3 functions as an effective activator of Ins2 by binding two GlisBS in its promoter regulatory region (6) . In this study, we show that SUFU was able to inhibit the induction of endogenous Ins2 expression in !-like INS1 (832/13) cells (Fig. 5A) . Moreover, SUFU caused up to a 50% decrease in Glis3-induced activation of the Ins2 promoter in these cells. This inhibition by SUFU was abrogated, however, when the SUFU YGH-binding motif in Glis3 was mutated or deleted by N-terminal truncation. The latter suggests that the inhibition of Glis3-mediated Ins2 transactivation by SUFU is dependent on the direct interaction of SUFU with Glis3 at the YGH motif. Although Glis2 was able to activate the Ins2 promoter in HEK293 cells, this activation was not affected by co-expression with SUFU. Similarly, SUFU had no significant effect on Glis1-induced activation of the Ins2 promoter. These results indicate that the effect of SUFU on Ins2 activation is specific for Glis3. The mechanism by which SUFU inhibits transcriptional activation by Glis3 is currently under further investigation. Repression of Gli activated target genes by SUFU has been thought to be the result of the cytoplasmic retention of Gli proteins (24, 26, (33) (34) (35) and/or by nuclear protein-protein interactions involving SAP18 and HDAC recruitment (24, (36) (37) (38) . Our data demonstrate that the inhibition of Glis3-mediated Ins2 activation by SUFU does not involve cytoplasmic sequestration of Glis3 as Glis3 remained localized to the nucleus in the presence of exogenous SUFU. In contrast, coexpression with Glis3 promoted the nuclear accumulation of SUFU, suggesting that SUFUmediated inhibition of Glis3 target genes is due to a mechanism that appears to be dependent on its nuclear localization and may involve a corepressor function of SUFU. Alternatively, several studies have linked inhibition of proteolytic degradation of transcription factors by proteasomes to a reduction in their transcriptional activity (39, 40) . Similarly, the inhibition of Glis3 ubiquitination and degradation by SUFU might be causally related to the observed repression of Glis3 transcriptional activity.
SUFU has been reported to play an important role in hedgehog signaling wherein it interacts with and regulates the activity of Gli proteins (32, 35, (41) (42) (43) . In contrast to Glis3, which promotes SUFU nuclear localization, SUFU restrains Gli1-3 to the cytoplasm resulting in the inhibition of transcriptional function. SUFU has been shown to co-localize to the primary cilium with Gli-proteins and while the functional consequence of their co-localization is still far from being understood, both primary ciliumdependent and -independent regulation of Gli proteins by SUFU have been reported (32, 33, 41, 42) . In this context it is interesting to note that Glis2 and Glis3 have also been localized to the primary cilium (7, 10, 44) . One might speculate that SUFU-Glis3 interaction might be functionally linked to the primary cilium and possibly involved in the regulation of Glis3 activity. However, future studies are required to elucidate the potential link between SUFU-Glis3 interaction, primary cilia, and Glis3 function.
Recent studies have shown that Glis3 has a critical role in both the development of pancreatic ! cells as well as in the regulation of insulin gene transcription (1, 6, 8, 17) . Interaction with SUFU and the consequent modulation of Glis3 protein stability moderate Glis3 activity and as a consequence are important in the regulation of Ins expression by Glis3. Mechanisms that stabilize and destabilize transcriptional regulators may play a critical role in the regulation of Ins expression in ! cells. In addition to Glis3, several other transcription factors, including Pdx1, MafA, and NeuroD1, have been implicated in the regulation of insulin gene transcription (45, 46) . Glis3 coactivator complexes have been reported to interact with adjacent Pdx1, MafA, and NeuroD1 protein complexes and act cooperatively in regulating insulin gene expression (1, 8) . Association with SUFU may affect pancreas development as well as the magnitude of Ins expression by influencing these interactions. Furthermore, in consideration of the fact that Glis3 is overexpressed in several cancers (47,48) and SUFU functions as a tumor suppressor (38, 49, 50) , defective interaction between these two proteins may be relevant to cancer development.
In summary, in this study we demonstrated that Glis3 interacted with SUFU through a VYGH motif within the homologous region at its N-terminus and that this interaction inhibited the polyubiquitination and degradation of Glis3, but repressed its transcriptional activity. We further provided evidence showing that Cul3-based complexes can promote Glis3 polyubiquitination and proteasome-dependent degradation of Glis3. SUFU inhibits the association between Cul3 and Glis3 thereby inhibiting Glis3 polyubiquitination and degradation. These observations allow for a possible model, shown in Figure 9 , whereby SUFU and Cul3, through their interaction with Glis3, control the stability and transcriptional activity of Glis3 and may fine-tune the regulation of gene expression by Glis3. This modulation of Glis3 activity by SUFU and Cul3 may play an important role in the mechanism by which Glis3 regulates the maintenance of pancreatic ! cell function and insulin gene expression. Cells were treated for 3 h with MG132 before they were harvested. Co-immunoprecipitations were carried out as described in Experimental Procedures using a rat-anti-HA-antibody. 
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